John Maraganore Insider Profile
18 Followers
John Maraganore, Director at Rapport Therapeutics, Inc., holds 9.41K shares in Rapport Therapeutics, Inc. (Ticker: RAPP), holds 24.20K shares in Takeda Pharmaceutical Company (Ticker: TAK), holds 230.80K shares in Alnylam Pharma (Ticker: ALNY). Most recently, John Maraganore Bought ― shares of Rapport Therapeutics, Inc. on Oct 22, 2026 for an estimated value of $248.80K.
John Maraganore's Trading History
| RAPPRapport Therapeutics, Inc. | Oct 22, 2026 | Director | Informative Buy | 248.80K | $233.58K | |
| CTYCity Therapeutics, Inc. | Oct 19, 2026 | Director | Uninformative Buy | ― | $35.79M | |
| TAKTakeda Pharmaceutical Company | Jul 06, 2026 | Director | Uninformative Buy | ― | $522.48K | |
| COAGHemab Therapeutics Holdings, Inc. | May 04, 2026 | Director | Uninformative Buy | ― | $1.40M | |
| AGIOAgios Pharma | May 24, 2022 | Director | Uninformative Buy | 33.44K | $905.34K | |
| ALNYAlnylam Pharma | Dec 23, 2021 | CEO, Director | Uninformative Buy | ― | $36.87M | |
| BLUEBluebird Bio | Sep 18, 2017 | ― | Uninformative Buy | 39.43K | $29.04K | |
| RGLSRegulus | Oct 11, 2012 | ― | Uninformative Buy | ― | $50.19M | |
| PROKProKidney | ― | Director | ― | ― | ||
| KYMRKymera Therapeutics | ― | Director | ― | ― | ||
| BEAMBeam Therapeutics | ― | Director | ― | ― |
You May Also Like
John Maraganore insider profile FAQ
What is the percentage of profitable transactions made by John Maraganore?
The percentage of profitable transactions made by John Maraganore is 47%.
What is the average return per transaction made by John Maraganore?
The average return per transaction made by John Maraganore is 43.80%.
What stocks does John Maraganore hold?
John Maraganore holds: RAPP, ALNY, TAK, BEAM, KYMR, PROK, COAG, CTY, AGIO, BLUE, RGLS stocks.
What was John Maraganore’s latest transaction?
John Maraganore’s latest transaction was an Informative Buy of $248.80K.
What was John Maraganore's most profitable transaction?
John Maraganore’s most profitable transaction was an Informative Buy of BLUE stock on July 14, 2014. The return on the trade was 386.00%.
What is John Maraganore's role in Rapport Therapeutics, Inc.?
John Maraganore's role in Rapport Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
